Like all medicines, this medication may cause some possible side effects but not everyone experiences them. Consult your healthcare professionals if any of the side effects lasts more than a few days, or become severe and bothersome.
The common side effects of oxcarbazepine include:
If the following serious side effects happen, you should go to the emergency department:
The symptoms of a drug allergy include one or more of the following and requires an emergency department visit:
Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TENS) are rare and serious skin reactions which can happen after using particular medications. Symptoms include face swelling, blisters on skin, skin rashes that spreads throughout the body within hours to days after taking the medication. It usually occurs within the first few months (monitor closely for the first 3 months) of treatment. Those who have been taking oxcarbazepine for more than 3 months without developing skin reactions are at low risk of SJS or TEN. As these skin reactions are rapidly progressing, caregivers should bring patient to emergency department if patient shows first sign of rash.
Inform your healthcare professionals if you have the following medical conditions before starting on oxcarbazepine:
For women: Inform your healthcare professionals if you are pregnant, plan to become pregnant, or are breastfeeding.
Consult your healthcare professional immediately if your seizures get worse or become different after you start on this medication.
Inform your healthcare professional that you are on oxcarbazepine.
Oxcarbazepine may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, injections, implants or intrauterine devices). Discuss with your healthcare professionals regarding birth control while on oxcarbazepine.
Avoid drinking alcohol while taking this medicine.
Please consult your healthcare professionals before using any other medications, including over-the-counter medicines, vitamins and herbal products.
Subscribe to our mailing list to get the updates to your inbox